Celeris Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Celeris Therapeutics's estimated annual revenue is currently $2.4M per year.
- Celeris Therapeutics's estimated revenue per employee is $100,500
Employee Data
- Celeris Therapeutics has 24 Employees.
- Celeris Therapeutics grew their employee count by 26% last year.
Celeris Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder, CEO & President | Reveal Email/Phone |
2 | CFO/COO, Co-Founder and Director | Reveal Email/Phone |
3 | Co-Founder and CFO/COO | Reveal Email/Phone |
4 | Head Platform | Reveal Email/Phone |
5 | Head Chemistry Lab | Reveal Email/Phone |
6 | VP, Head Drug Discovery and London Office | Reveal Email/Phone |
7 | Program Manager | Reveal Email/Phone |
8 | Program Manager | Reveal Email/Phone |
9 | Business Development Manager | Reveal Email/Phone |
10 | Principal Computational Chemist | Reveal Email/Phone |
Celeris Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.4M | 24 | 26% | N/A | N/A |
What Is Celeris Therapeutics?
Celeris Therapeutics is going to solve the R&D shortcomings as the pioneer in AI-driven PIC (proximity-inducing compounds) design using an innovative closed-loop engine (Celeris One™ platform) to develop new chemical entities (NCEs) that degrade proteins by establishing proximity to endogenous cellular mechanisms. The solutions include machine learning-driven prediction of interactions, generative design, optimization of molecular properties, and automation of laboratory devices. CelerisTx's drug pipeline is focused on CNS and oncology, targeting unmet medical needs. We also co-develop therapeutics with pharmaceutical and biotech companies. CelerisTx has so far attracted a total of EUR 18 million in committed capital from venture capital funds, which include EIC Fund, Pace Ventures Enigma, i&i biotech, Apex Ventures, R42 and longevitytech.fund. #targetedproteindegradation #degrader #ubiquitinproteasomesystem #machinelearning #CelerisOne #proximityinducingcompounds #PICs
keywords:N/A
N/A
Total Funding
24
Number of Employees
$2.4M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.5M | 24 | 0% | N/A |
#2 | $6M | 24 | -29% | N/A |
#3 | $3.4M | 24 | 9% | N/A |
#4 | $2.4M | 24 | N/A | N/A |
#5 | $2.4M | 24 | 0% | N/A |